Yuhuan Zheng

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Venues

Cell death & disease

Cancer medicine

British journal of haematology

ACS omega

University of South Dakota (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of South Dakota

United States

PHD

Publications

Zhimei Lin, Yue Zhang, Xiang Liu, Hongmei Luo, Qian Li, Qianwen Gao, Xin Wang, Jingjing Wen, Linfeng Li, Yu Feng, Fangfang Wang, Jingcao Huang, Xinyu Zhai, Li Zhang, Ting Niu, Yuhuan Zheng
Decreased RNA-binding protein heterogeneous nuclear ribonucleoprotein U improves multiple myeloma sensitivity to lenalidomide. British journal of haematology 205 (2) (2024)
Yu Feng, Hongmei Luo, Jingcao Huang, Yue Zhang, Jingjing Wen, Linfeng Li, Ziyue Mi, Qianwen Gao, Siyao He, Xiang Liu, Xinyu Zhai, Xin Wang, Li Zhang, Ting Liu, Yuhuan Zheng
Dihydrolipoamide dehydrogenase (DLD) is a novel molecular target of bortezomib. Cell death & disease 15 (8) (2024)
Wenjiao Tang, Yan Li, Li Zhang, Xushu Zhong, Qiushi Liang, Yuhuan Zheng, Yuzhang Liu, Yafei Wang, Xunqiang Wang, Yun Zeng, Baijun Fang, Li Zheng, Ting Niu
Phase I study of TQB3602, an oral proteasome inhibitor, in relapsed and refractory multiple myeloma. Cancer medicine 13 (14) (2024)
Yu Feng, Hongmei Luo, Jingcao Huang, Yue Zhang, Jingjing Wen, Linfeng Li, Ziyue Mi, Qianwen Gao, Siyao He, Xiang Liu, Xinyu Zhai, Xin Wang, Li Zhang, Ting Liu, Yuhuan Zheng
Dihydrolipoamide dehydrogenase (DLD) is a novel molecular target of bortezomib. Cell death & disease 15 (8) (2024)
Yanqiu Xiong, Shan-Shan Liang, Wenjiao Tang, Li Zhang, Yuhuan Zheng, Ling Pan, Ting Niu
A predictive risk-scoring model for survival prognosis of multiple myeloma based on gain/amplification of 1q21: Experience in a tertiary hospital in South-Western China. Cancer medicine 13 (17) (2024)
Zhimei Lin, Yue Zhang, Xiang Liu, Hongmei Luo, Qian Li, Qianwen Gao, Xin Wang, Jingjing Wen, Linfeng Li, Yu Feng, Fangfang Wang, Jingcao Huang, Xinyu Zhai, Li Zhang, Ting Niu, Yuhuan Zheng
Decreased RNA-binding protein heterogeneous nuclear ribonucleoprotein U improves multiple myeloma sensitivity to lenalidomide. British journal of haematology (2024)
Yu Feng, Hongmei Luo, Jingcao Huang, Yue Zhang, Jingjing Wen, Linfeng Li, Ziyue Mi, Qianwen Gao, Siyao He, Xiang Liu, Xinyu Zhai, Xin Wang, Li Zhang, Ting Liu, Yuhuan Zheng
Dihydrolipoamide dehydrogenase (DLD) is a novel molecular target of bortezomib. Cell death & disease 15 (8) (2024)
Wenjiao Tang, Yan Li, Li Zhang, Xushu Zhong, Qiushi Liang, Yuhuan Zheng, Yuzhang Liu, Yafei Wang, Xunqiang Wang, Yun Zeng, Baijun Fang, Li Zheng, Ting Niu
Phase I study of TQB3602, an oral proteasome inhibitor, in relapsed and refractory multiple myeloma. Cancer medicine 13 (14) (2024)
Xinyuan Gu, Chunyan Sun, Juan Xu, Zhimei Lin, Li Zhang, Yuhuan Zheng
Optimal timing and drug combination of selinexor in multiple myeloma: a systematic review and meta-analysis. Hematology (Amsterdam, Netherlands) 28 (1) (2023)
Zhimei Lin, Bingyang Chu, Ying Qu, Xue Wei, Jingcao Huang, Fangfang Wang, Yu Feng, Xin Wang, Hongmei Luo, Xinyu Zhai, Juan Xu, Xiang Liu, Li Zhang, Fengjiao Chen, Yu Wu, Yuhuan Zheng
Liposome-Encapsulated Melphalan Exhibits Potent Antimyeloma Activity and Reduced Toxicity. ACS omega 8 (1) (2022)
Fangfang Wang, Zhang Dan, Hongmei Luo, Jingcao Huang, Yushan Cui, Hong Ding, Juan Xu, Zhimei Lin, Yuhan Gao, Xinyu Zhai, Yan Yang, Ying Qu, Li Zhang, Fengjiao Chen, Qiang Wang, Xin Wang, Yu Feng, Ting Liu, Qing Yi, Ting Niu, Yuhuan Zheng
ALCAM regulates multiple myeloma chemoresistant side population. Cell death & disease 13 (2) (2022)
Yushan Cui, Fangfang Wang, Danfeng Zhang, Jingcao Huang, Yan Yang, Juan Xu, Yuhan Gao, Hong Ding, Ying Qu, Wenyan Zhang, Weiping Liu, Ling Pan, Li Zhang, Zhigang Liu, Ting Niu, Ting Liu, Yuhuan Zheng
Estrogen-Responsive Gene MAST4 Regulates Myeloma Bone Disease. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 37 (4) (2022)
Fengjiao Chen, Yamei Leng, Jingyao Ni, Ting Niu, Li Zhang, Ji-Ping Li, Yuhuan Zheng
Symptom clusters and quality of life in ambulatory patients with multiple myeloma. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 30 (6) (2022)
Zhimei Lin, Bingyang Chu, Ying Qu, Xue Wei, Jingcao Huang, Fangfang Wang, Yu Feng, Xin Wang, Hongmei Luo, Xinyu Zhai, Juan Xu, Xiang Liu, Li Zhang, Fengjiao Chen, Yu Wu, Yuhuan Zheng
Liposome-Encapsulated Melphalan Exhibits Potent Antimyeloma Activity and Reduced Toxicity. ACS omega 8 (1) (2022)
Fengjiao Chen, Yamei Leng, Jiping Li, Yuhuan Zheng
Compassion satisfaction and compassion fatigue in haematology cancer nurses: A cross-sectional survey. Nursing open 9 (4) (2022)
Danfeng Zhang, Jingcao Huang, Fangfang Wang, Hong Ding, Yushan Cui, Yan Yang, Juan Xu, Hongmei Luo, Yuhan Gao, Ling Pan, Yu Wu, Yuping Gong, Liping Xie, Zhigang Liu, Ying Qu, Li Zhang, Weiping Liu, Wenyan Zhang, Sha Zhao, Qing Yi, Ting Niu, Yuhuan Zheng
BMI1 regulates multiple myeloma-associated macrophage's pro-myeloma functions. Cell death & disease 12 (5) (2021)
Hong Ding, Juan Xu, Zhimei Lin, Jingcao Huang, Fangfang Wang, Yan Yang, Yushan Cui, Hongmei Luo, Yuhan Gao, Xinyu Zhai, Weicui Pang, Li Zhang, Yuhuan Zheng
Minimal residual disease in multiple myeloma: current status. Biomarker research 9 (1) (2021)
Pan Zhao, Jingcao Huang, Dan Zhang, Danfeng Zhang, Fangfang Wang, Ying Qu, Tingting Guo, Yu Qin, Jin Wei, Ting Niu, Yuhuan Zheng
SLC2A5 overexpression in childhood philadelphia chromosome-positive acute lymphoblastic leukaemia. British journal of haematology 183 (2) (2018)

Yuhuan Zheng.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yuhuan Zheng